Skip to main content
. 2021 Oct 19;16(10):e0258858. doi: 10.1371/journal.pone.0258858

Fig 1. US diverse enrollment across the NIH-funded Moderna, AstraZeneca, J&J, and Novavax trials.

Fig 1